Skip to main content
Egyptian Liver Journal

Table 5 Hepcidin (ng/ml) comparison among the three study groups

From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma

 

Group I (n = 30)

Group II (n = 30)

Group III (n = 30)

H

p

Hepcidin (ng/ml)

 Min.–max.

0.65–4.0

0.82–4.0

0.75–1.99

10.880*

0.004*

 Mean ± SD.

1.33 ± 0.57

1.16 ± 0.56

1.17 ± 0.24

 Median (IQR)

1.31 (1.13–1.39)

1.02 (0.96–1.16)

1.12 (1.04–1.23)

Sig. bet. grps.

p1 = 0.001*, p2 = 0.122, p3 = 0.080

  
  1. IQR Interquartile range. SD Standard deviation. H H for Kruskal-Wallis test, the post hoc test, commonly known as the Dunn’s test for multiple comparisons, was used to compare the two groups in pairs. p p-value to compare the three study involved groups. p1 p-value to compare group I and group II. p2 p-value to compare group I and group III. p3 p-value to compare group II and group III. *Statistical significance at p ≤ 0.05. Group I, individuals diagnosed with cirrhosis but no HCC. Group II, cirrhotic individuals with HCC. Group III, healthy controls
Back to article page